AXSM (AXSM) Stock Price & Analysis
AXSM (AXSM) fell 0.80% to USD 206.68 as of September 8, 2026 at 05:44 UTC, according to Nexqual real-time market data.
AXSM last closed at USD 206.68; the session ranged USD 205.49–208.51 on volume of 438,242 shares. Market capitalization is —, with a 52-week range of USD 112.9–260.19 (NGM). Source: Nexqual, September 8, 2026 at 05:44 UTC.
Key Statistics (as of September 8, 2026 at 05:44 UTC)
| Price | USD 206.68 |
|---|---|
| Change | ▼ 0.80% (down) |
| Previous Close | USD 206.68 |
| Open | USD 206.68 |
| Day Range | USD 205.49 – 208.51 |
| 52-Week Range | USD 112.9 – 260.19 |
| Volume | 438,242 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (AXSM)
Nexqual's technical model rates AXSM "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 05:44 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 40.69 (neutral) |
| vs SMA50 | Below (USD 223.76) |
| MACD | -5.03 (negative) |
From AXSM's Latest SEC 10-K Filing (filed 2026-02-23)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TGTX | TG Therapeutics, Inc. | USD 55.99 | ▼ 1.61% |
| MDGL | Madrigal Pharmaceuticals, Inc. | USD 541.08 | ▼ 1.07% |
| AUPH | Aurinia Pharmaceuticals Inc | USD 16.08 | ▼ 1.29% |
| BBIO | BridgeBio Pharma, Inc. | USD 74.84 | ▼ 2.17% |
| IOVA | Iovance Biotherapeutics, Inc. | USD 8.79 | ▲ 1.97% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:44 UTC. This page is informational and not investment advice.